VeriSIM Life

About:

VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials.

Website: http://verisimlife.com/

Twitter/X: VeriSIMlife

Top Investors: National Science Foundation, Intel Capital, Village Global, Susa Ventures, Serra Ventures

Description:

VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. VeriSIM offers a range of translational-based solutions, customized for the pre-clinical and clinical programs. These offerings are all centered around their proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses.

Total Funding Amount:

$21.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)verisimlife.com

Founders:

Jo Varshney

Number of Employees:

11-50

Last Funding Date:

2022-01-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai